What are the benefits of combining Sitagliptin with SGLT2 inhibitors, and how does this dual therapy improve glycemic outcomes and cardiovascular health?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Combining Sitagliptin with SGLT2 inhibitors enhances glycemic control by utilizing complementary mechanisms—Sitagliptin increases insulin while SGLT2 inhibitors expel glucose via urine. This synergy also reduces cardiovascular risks by lowering blood pressure and aiding weight loss.